Full history for every metric is available with a Kvantra account

Stock profile
AddLife AB (publ) logo

AddLife AB (publ) (ALIF-B.ST)

Country: SwedenSector: HealthcareIndustry: Medical - Instruments & SuppliesExchange: STO
P/E TTM
35.1
History
P/E NTM
33.4
Market cap
21.64B
Currency SEK
KvantraRankAbout64
IValue68
IIQuality67
IIIMomentum54
Current price
184.50 SEK+2.39%
Close 4 Nov 2026
Interval
Benchmarks

Key financial summary

Financials in SEK
202020212022202320242025TTM2026E
Total revenueSEK bn5.38.09.19.710.310.410.711.0
Operating profitSEK bn0.780.83
Net profitSEK bn0.520.720.480.190.250.560.640.55
EPS reportedSEK4.605.26
Operating cashflow per shareSEK11.4211.43
Capex per shareSEK2.332.19
FCF per shareSEK9.099.24
Free cash flowSEK bn1.111.13
Net debtSEK bn3.464.66
Book value equitySEK bn5.445.95
Book value per shareSEK44.6648.86
Number of sharesm121.86121.86
DPS (TTM paid)SEK1.501.50

Financial summary

Financials in SEK
202020212022202320242025TTM2026E
Value
P/E TTMx34.5935.08
P/B LTMx3.563.63
P/S LTMx1.862.02
P/FCF LTMx17.5019.22
EV/EBITDA LTMx12.9615.99
EV/Sales LTMx2.242.46
Earnings Yield LTM%2.89%2.85%
FCF Yield%5.71%5.20%
Quality
ROE%10.29%11.32%
ROIC%5.33%5.19%
Operating margin%7.47%7.77%
Gross margin%38.09%38.67%
FCF/Sales%10.61%10.53%
Growth and momentum
EPS Growth YoY%+122.22%+62.85%
Sales Growth YoY%+1.52%+1.62%
Net Income Growth YoY%+122.22%+63.45%
FCF Growth%+38.85%+22.79%
Operating Profit Growth%+8.18%+0.85%
Dividend and capital structure
Dividend Yield%0.47%0.81%
Dividend Growth%+100.00%+100.00%
Payout Ratio%16.23%28.39%
FCF/Debtx0.230.22
Net Debt/EBITDAx2.202.83
EBIT/Net interestx3.684.72
Net debt/market cap%17.83%21.54%
Net debt/Equityx0.640.78
Gross debt/equityx0.880.86

Ratings

Strong Buy
Buy
Hold
Sell
Strong Sell
Number of covering analysts

Based on consensus from external analysts. Not Kvantra's opinion.

Company overview

AddLife AB (publ), a company established in 1906 and headquartered in Stockholm, Sweden, specializes in delivering cutting-edge equipment, medical apparatus, and chemical reagents. Its primary clientele includes the healthcare sector, academic and research organizations (such as colleges and universities), and key players within the food and pharmaceutical industries. The firm's operations are divided into two distinct divisions: Labtech and Medtech. The Labtech segment provides a comprehensive array of products, integrated solutions, and expert services, focusing on diagnostics, biomedical research, and general laboratory requirements. This encompasses specialized instruments for areas like haematology, pathology, immediate diagnostic testing (point-of-care), cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, along with consumables and advanced analytical machinery. This division further offers vital support, maintenance, consultancy, and educational programs. Conversely, the Medtech segment concentrates on supplying a wide range of medical devices tailored for critical applications such as surgical procedures, respiratory support, intensive care, wound management, and enteral nutrition. It also develops products for fall prevention, welfare technology, and ear, nose, and throat conditions, in addition to offering specific assistive devices for bathrooms and specialized aids for children with disabilities. AddLife maintains a broad international presence, conducting business in its home country of Sweden, across the Nordics (Finland, Denmark, Norway), the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, other parts of Europe, and globally.

Websiteadd.life
Trades inSEK

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

AddLife AB (publ) (ALIF-B.ST)

ALIF-B.ST · STO · Healthcare
184.50 SEK+2.39%
Sign up to track this stock
Benchmarks
KvantraRank64
Market cap21.64B
P/E NTM33.4
P/E TTM35.1
KvantraRank?64 / 100
Value
68
Quality
67
Momentum
54
Financialsin SEK
20242025TTM2026E
Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Based on consensus from external analysts. Not Kvantra's opinion.

About

AddLife AB (publ), a company established in 1906 and headquartered in Stockholm, Sweden, specializes in delivering cutting-edge equipment, medical apparatus, and chemical reagents. Its primary clientele includes the healthcare sector, academic and research organizations (such as colleges and universities), and key players within the food and pharmaceutical industries. The firm's operations are divided into two distinct divisions: Labtech and Medtech. The Labtech segment provides a comprehensive array of products, integrated solutions, and expert services, focusing on diagnostics, biomedical research, and general laboratory requirements. This encompasses specialized instruments for areas like haematology, pathology, immediate diagnostic testing (point-of-care), cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, along with consumables and advanced analytical machinery. This division further offers vital support, maintenance, consultancy, and educational programs. Conversely, the Medtech segment concentrates on supplying a wide range of medical devices tailored for critical applications such as surgical procedures, respiratory support, intensive care, wound management, and enteral nutrition. It also develops products for fall prevention, welfare technology, and ear, nose, and throat conditions, in addition to offering specific assistive devices for bathrooms and specialized aids for children with disabilities. AddLife maintains a broad international presence, conducting business in its home country of Sweden, across the Nordics (Finland, Denmark, Norway), the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, other parts of Europe, and globally.

Websiteadd.life
IndustryMedical - Instruments & Supplies
CountrySweden
Trades inSEK

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free